Corebridge Financial’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,595
| Closed | -$316K | – | 2478 |
|
|
2025
Q1 | $316K | Buy |
19,595
+2,382
| +14% | +$38.4K | ﹤0.01% | 1825 |
|
|
2024
Q4 | $401K | Sell |
17,213
-1,299
| -7% | -$30.2K | ﹤0.01% | 1797 |
|
|
2024
Q3 | $544K | Sell |
18,512
-113
| -0.6% | -$3.32K | ﹤0.01% | 1688 |
|
|
2024
Q2 | $438K | Buy |
+18,625
| New | +$438K | ﹤0.01% | 1763 |
|